Can L. Plantarum Help with Mood?
Yes, Lactobacillus plantarum probiotics can improve mood in adults with mild-to-moderate depression or anxiety, with the strongest evidence supporting a dose of 5 billion CFU daily for at least 4-6 weeks.
Strongest Evidence for Anxiety Reduction
The most recent and highest-quality evidence comes from a 2025 randomized, double-blind, placebo-controlled trial demonstrating that Lactiplantibacillus plantarum Lp815 at 5 billion CFU daily significantly reduced anxiety scores (GAD-7) at weeks 4 and 6 compared to placebo 1. This effect was clinically meaningful: 68% of participants receiving 5 billion CFU improved by at least one anxiety category (e.g., from moderate to no anxiety), compared to only 26% in the placebo group 1. Importantly, no serious adverse events occurred 1.
Dose-Response Relationship
- 5 billion CFU daily is the effective dose for anxiety reduction, showing significant benefits at 4 and 6 weeks 1
- 1 billion CFU daily showed intermediate effects (37% improvement rate) but did not reach statistical significance compared to placebo 1
- The lower dose appears insufficient for robust clinical benefit 1
Evidence for Depression
L. plantarum combined with S-adenosylmethionine (SAMe) 200 mg significantly improved mild-to-moderate depression symptoms within 2 weeks, with sustained effects at 6 weeks 2. The combination reduced:
- Total depression scores (Zung Self-Rating Depression Scale) at both 2 and 6 weeks 2
- Cognitive and anxiety subdomains at 2 weeks 2
- Core depression symptoms at 6 weeks 2
A 2024 meta-analysis confirmed that probiotics containing L. plantarum (along with other Lactobacillus and Bifidobacterium species) significantly reduced depressive symptoms when measured by the Beck Depression Inventory (BDI), with a mean difference of -2.69 points 3.
Mechanisms of Action
L. plantarum strains exert mood benefits through multiple pathways:
- GABA production: L. plantarum produces gamma-aminobutyric acid, the brain's primary inhibitory neurotransmitter, which has anxiolytic and sedative effects 1
- Gut-brain axis modulation: 12-week supplementation with L. plantarum P-8 enhanced diversity of neurotransmitter-synthesizing gut bacteria and increased predicted levels of GABA, short-chain fatty acids, and other neuroactive metabolites 4
- Neuroinflammation reduction: L. plantarum decreases NLRP3 inflammasome expression and increases brain-derived neurotrophic factor (BDNF) levels, promoting neural repair and reducing neurodegeneration 5
- Microbiome stabilization: Probiotic treatment prevented the decrease in gut microbiome diversity typically seen with chronic stress 4
Clinical Implementation Algorithm
For anxiety (primary indication):
- Prescribe L. plantarum Lp815 at 5 billion CFU once daily 1
- Continue for minimum 4 weeks; optimal duration is 6 weeks 1
- Assess response using validated anxiety scales (e.g., GAD-7) 1
For depression:
- Consider L. plantarum HEAL9 (1 × 10⁹ CFU) combined with SAMe 200 mg daily 2
- Expect initial response within 2 weeks, with full effects by 6 weeks 2
- This combination is particularly useful for subthreshold or mild-to-moderate symptoms where traditional antidepressants show minimal benefit 2
For comorbid anxiety and depression:
- Start with the L. plantarum + SAMe combination, which addresses both symptom domains 2
- Monitor cognitive reactivity to negative mood, as L. plantarum formulations reduce rumination 6
Important Caveats
Measurement scale matters: While probiotics containing L. plantarum show significant effects on BDI scores, effects measured by Hamilton Depression Rating Scale (HAMD), DASS, or MADRS were not statistically significant in meta-analysis 3. This suggests benefits may be more apparent in self-reported symptoms versus clinician-rated scales.
Not a monotherapy for severe illness: Current guidelines do not support probiotics as standalone treatment for moderate-to-severe depression or anxiety requiring psychiatric intervention 7. For patients with severe psychiatric illness, suicidal ideation, or impaired quality of life, refer to psychiatry while considering probiotics as adjunctive therapy 7.
Strain specificity is critical: The evidence supports specific L. plantarum strains (Lp815, P-8, HEAL9, NBIMCC 8767) at defined doses 1, 4, 2, 5. Generic "L. plantarum" products without strain identification should not be assumed equivalent.
Responder variability: Positive responders to probiotic treatment show increased abundance of the administered probiotic genera in their gut microbiota, suggesting that baseline microbiome composition may predict treatment response 6.
Safety Profile
L. plantarum probiotics demonstrate excellent safety in clinical trials, with no treatment-related adverse events reported in the anxiety trial 1 or the depression combination study 2. This favorable safety profile makes them appropriate for real-world clinical use in mild-to-moderate mood disorders.